A phase I trial of caffeine to evaluate safety in infants with hypoxic-ischemic encephalopathy. Jackson W, Gonzalez D, Greenberg RG, Lee YZ, et al. J Perinatol 2023 Aug 16. doi: 10.1038/s41372-023-01752.

Read + Share

Amedeo Smart

Independent Medical Education

Jackson W, Gonzalez D, Greenberg RG, Lee YZ, et al. A phase I trial of caffeine to evaluate safety in infants with hypoxic-ischemic encephalopathy. J Perinatol 2023 Aug 16. doi: 10.1038/s41372-023-01752.
PMID: 37587184